Great Diamond Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $791K | Buy |
1,776
+423
| +31% | +$188K | 0.17% | 126 |
|
|
2025
Q1 | $656K | Buy |
1,353
+338
| +33% | +$164K | 0.18% | 100 |
|
|
2024
Q4 | $409K | Sell |
1,015
-12
| -1% | -$4.83K | 0.11% | 123 |
|
|
2024
Q3 | $478K | Sell |
1,027
-682
| -40% | -$317K | 0.12% | 119 |
|
|
2024
Q2 | $801K | Sell |
1,709
-34
| -2% | -$15.9K | 0.19% | 102 |
|
|
2024
Q1 | $729K | Sell |
1,743
-16
| -0.9% | -$6.69K | 0.17% | 112 |
|
|
2023
Q4 | $716K | Buy |
1,759
+21
| +1% | +$8.55K | 0.18% | 114 |
|
|
2023
Q3 | $604K | Buy |
1,738
+1
| +0.1% | +$348 | 0.16% | 119 |
|
|
2023
Q2 | $611K | Buy |
1,737
+139
| +9% | +$48.9K | 0.16% | 118 |
|
|
2023
Q1 | $503K | Sell |
1,598
-203
| -11% | -$64K | 0.15% | 125 |
|
|
2022
Q4 | $520K | Sell |
1,801
-116
| -6% | -$33.5K | 0.16% | 119 |
|
|
2022
Q3 | $555K | Sell |
1,917
-83
| -4% | -$24K | 0.19% | 107 |
|
|
2022
Q2 | $563K | Sell |
2,000
-483
| -19% | -$136K | 0.19% | 104 |
|
|
2022
Q1 | $647K | Sell |
2,483
-153
| -6% | -$39.9K | 0.18% | 104 |
|
|
2021
Q4 | $578K | Sell |
2,636
-38
| -1% | -$8.33K | 0.15% | 119 |
|
|
2021
Q3 | $485K | Buy |
+2,674
| New | +$485K | 0.13% | 123 |
|
|
2020
Q1 | – | Sell |
-34
| Closed | -$7K | – | 596 |
|
|
2019
Q4 | $7K | Buy |
+34
| New | +$7K | ﹤0.01% | 584 |
|